Beihai Gofar Chuanshan Biological Co., Ltd. (600538.SS)

CNY 5.0

(-2.91%)

Market Cap (In CNY)

2.62 Billion

Revenue (In CNY)

369.15 Million

Net Income (In CNY)

-82.3 Million

Avg. Volume

6.7 Million

Currency
CNY
Country
Basic Materials
Open
-
Prev. Close
-
Day Range
-
Year Range
2.9-5.8
PE
-
EPS
-
Beta Value
-0.427
ISIN
CNE000001DD2
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Basic Materials
Industry
Agricultural Inputs
CEO
Dr. Bin Pan Li
Employee Count
-
Website
https://www.gofar.com.cn
Ipo Date
2003-01-14
Details
Beihai Gofar Chuanshan Biological Co., Ltd. engages in the production and distribution of pharmaceutical products in China. The company offers various medicines and medical devices; and produces and sells pearl eyesight eye drops, gastrointestinal granules, pearl powder, and other proprietary Chinese medicines. It also provides molecular medical imaging and tumor radiotherapy centers, as well as tumor telemedicine technical services. The company was formerly known as Beihai Gofar Marine Biological Industry Co., Ltd. and changed its name to Beihai Gofar Chuanshan Biological Co., Ltd. in May 2021. Beihai Gofar Chuanshan Biological Co., Ltd. was founded in 1993 is based in Beihai, China.